Home > Insider Trading > Filing (0000878088-11-000046)

Filing Details

Accession Number:: 0000878088-11-000046
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-05-11 16:34:59
Reporting Period:: 2011-05-09

Filing Date:: 2011-05-11
Accepted Time:: 2011-05-11 16:34:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
878088	Par Pharmaceutical Companies Inc.	PRX	Pharmaceutical Preparations (2834)	223122182

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1055404	G Patrick Lepore	C/O Par Pharmaceutical Companies, Inc. 300 Tice Boulevard Woodcliff NJ 07677	Chairman, President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-05-09	65,467	$13.06	329,037	No	4	M	Direct
Common Stock	Disposition	2011-05-09	26,100	$34.00	302,937	No	4	S	Direct
Common Stock	Disposition	2011-05-09	200	$34.03	302,737	No	4	S	Direct
Common Stock	Disposition	2011-05-09	1,500	$34.09	301,237	No	4	S	Direct
Common Stock	Disposition	2011-05-09	500	$34.10	300,737	No	4	S	Direct
Common Stock	Disposition	2011-05-09	100	$34.16	300,637	No	4	S	Direct
Common Stock	Disposition	2011-05-09	800	$34.17	299,837	No	4	S	Direct
Common Stock	Disposition	2011-05-09	300	$34.20	299,537	No	4	S	Direct
Common Stock	Disposition	2011-05-09	300	$34.21	299,237	No	4	S	Direct
Common Stock	Disposition	2011-05-09	8,700	$34.21	290,537	No	4	S	Direct
Common Stock	Disposition	2011-05-09	400	$34.23	290,137	No	4	S	Direct
Common Stock	Disposition	2011-05-09	500	$34.24	289,637	No	4	S	Direct
Common Stock	Disposition	2011-05-09	176	$34.25	289,461	No	4	S	Direct
Common Stock	Disposition	2011-05-09	5,402	$34.26	289,059	No	4	S	Direct
Common Stock	Disposition	2011-05-09	500	$34.26	283,559	No	4	S	Direct
Common Stock	Disposition	2011-05-09	200	$34.28	283,359	No	4	S	Direct
Common Stock	Disposition	2011-05-09	700	$34.29	282,659	No	4	S	Direct
Common Stock	Disposition	2011-05-09	9,804	$34.30	272,855	No	4	S	Direct
Common Stock	Disposition	2011-05-09	400	$34.30	272,455	No	4	S	Direct
Common Stock	Disposition	2011-05-09	200	$34.35	272,255	No	4	S	Direct
Common Stock	Disposition	2011-05-09	6,309	$34.42	265,946	No	4	S	Direct
Common Stock	Disposition	2011-05-09	45	$34.43	265,901	No	4	S	Direct
Common Stock	Disposition	2011-05-09	2,331	$34.44	263,570	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock, Option to Buy	Disposition	2011-05-09	65,467	$0.00	65,467	$13.06

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
65,467		2019-01-07	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	15,000	Indirect	By Limited Partnership
Common Stock	15,000	Indirect	By Trust

Footnotes

Includes (i) 141,646 shares of Common Stock, and (ii) 121,924 shares of Restricted Stock and Restricted Stock Units held by Mr. LePore.
The shares are held by Park Street Investors, L.P. ("PSI"), a Delaware limited partnership. The General Partner of PSI is Park Street Investment Corporation ("PSIC"), a Delaware corporation, of which Mr. LePore and his spouse are officers and directors and together own a majority of the outstanding stock of PSIC.
The shares are held by the Patrick LePore Revocable Trust of 2002, of which Mr. LePore is the Grantor, Trustee and beneficiary.
Mr. LePore was granted an option to purchase shares of Common Stock under the Company's 2004 Performance Equity Plan. 25% (32,733 shares) vested on 1/8/2010 (the first anniversary of the date of grant); an additional 25% vest on each anniversary thereafter until fully vested.